1. Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. Issue 9 (1st November 2019) Authors: Guidi, Luisa; Pugliese, Daniela; Tonucci, Tommaso Panici; Bertani, Lorenzo; Costa, Francesco; Privitera, Giuseppe; Tolusso, Barbara; Di Mario, Clara; Albano, Eleonora; Tapete, Gherardo; Gremese, Elisa; Papa, Alfredo; Gasbarrini, Antonio; Rapaccini, Gian Ludovico; Armuzzi, Alessandro Journal: United European Gastroenterology journal Issue: Volume 7:Issue 9(2019) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. Issue 9 (November 2019) Authors: Guidi, Luisa; Pugliese, Daniela; Tonucci, Tommaso Panici; Bertani, Lorenzo; Costa, Francesco; Privitera, Giuseppe; Tolusso, Barbara; Di Mario, Clara; Albano, Eleonora; Tapete, Gherardo; Gremese, Elisa; Papa, Alfredo; Gasbarrini, Antonio; Rapaccini, Gian Ludovico; Armuzzi, Alessandro Journal: United European Gastroenterology journal Issue: Volume 7:Issue 9(2019) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗